Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gut Hormone Test Predicts Efficacy of Gastric Bypass

By LabMedica International staff writers
Posted on 19 Nov 2013
A hormone test may be able to predict the extent of metabolic improvement caused by the gastric bypass, one of the most commonly performed surgical procedures in the treatment of obesity.

In most patients, gastric bypass surgery quickly produces substantial body weight loss and even before the weight loss, the procedure leads to improved glucose tolerance, but these metabolic improvements vary considerably from patient to patient.

Scientists at University of Cincinnati (OH, USA) and the Helmholtz Zentrum München (Munich, Germany) studied the concentration of the gut hormone glucagon-like peptide 1 (GLP-1) in a rodent diet-induced-obesity model. More...
Blood glucose was determined with a Freestyle Glucometer (Abbott Diabetes Care; Alameda, CA, USA).

Active and total GLP-1 was measured by electrochemiluminescence assay (Meso Scale Discovery; Gaithersburg, MD, USA). After gastric bypass surgery, the concentration of the gut hormone GLP-1 in the blood rises significantly. GLP-1 increases insulin secretion and contributes to improved blood glucose levels and blood lipids. In the rodent study, GLP-1 responsiveness varied considerably with regard to glucose metabolism and more importantly, the more responsive the animals were to GLP-1, the greater the efficacy of the gastric bypass turned out to be regarding glucose metabolism improvements.

The authors concluded that the GLP-1 system may offer untapped potential as a novel biomarker for personalized approaches to the treatment of type 2 diabetes (T2D) and obesity. Clinical studies in obese and T2D patients will be required to test if this desirable novel biomarker shows the same, or even greater, promise in humans and can be used to predict benefits, as well as to prevent unnecessary risks of bariatric surgeries.

Matthias H. Tschöp, MD, a professor and a senior author of the study said, “If our results are confirmed in clinical trials with patients, the hormone response could be tested before the planned surgery and surgeons would be able to predict how much an individual patient's glucose metabolism would benefit. This will contribute to the development of personalized therapies for type 2 diabetes and obesity. For surgical procedures such as gastric bypass this is particularly compelling because such operations are complex and cannot be easily reversed.” The study was published on November 1, 2013, in the journal Diabetes.

Related Links:

University of Cincinnati
Helmholtz Center Munich
Meso Scale Discovery



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.